Pharma undergoes a slight shuffling of its r&d operations.

Websep 18, 2023 · gsk’s senior vice president and head of research john lepore, m. d. , has left the company at the same time the u. k.

Is at a “tipping point” and risks falling short of government ambitions to become a life sciences.

Recommended for you

It is believed about 200 roles will be cut at the facility in barnard castle,.

Webfeb 2, 2023 · gsk chief executive officer emma walmsley warned the u. k.

Websep 9, 2024 · pharmaceutical firm glaxosmithkline (gsk) has confirmed job losses at one of its uk sites.

You may also like